Assisted Reproduction Safety and Risks

Adverse Incidents in Fertility Clinics: Lessons to Learn 2013

Human Fertilisation and Embryology Authority

2014

RRM Academy Synopsis

UK fertility clinics reported 516 adverse incidents in 2013

UK fertility clinics reported 516 adverse incidents in 2013, against 514 in 2012, in an annual report from their regulator, the HFEA. Just under half were clinical, mostly linked to ovarian hyperstimulation syndrome (OHSS). The HFEA estimates about 1 out of 100 IVF cycles involves an adverse incident.

Key Findings

  • Four incidents received A grade, against one in each of 2010, 2011 and 2012. They included a failed storage tank holding donor sperm samples belonging to 250 patients.
  • Most administrative incidents were breaches of confidentiality, chiefly information sent to an incorrect address.
  • Reports of OHSS included about 46 severe cases, down from 60 in 2012, and 160 mild or moderate cases, a slight rise that the report calls not statistically significant.
  • The 251 clinical incidents outnumbered 126 in the laboratory and 90 in administration, and 49 incidents fit none of those categories.
  • Of the 516 reports, 208 were B grade and 262 were C grade; the other 42 were near misses or not incidents.

Interpretation

The report is a regulator's annual summary of incidents reported by licensed UK clinics. Each incident was graded by severity and assigned to one category. Counts depend on clinic reporting: the HFEA requires reports of OHSS only when it is severe and leads to hospital admission, although clinics also report milder episodes. The report has no comparison group and describes the 2013 changes in B grade and C grade counts as random variations. The 2013 figures predate the first incident report, published in July 2014, and cannot reflect improvements made in response to it.

RRM Context

The clinical incidents in this report relate mostly to OHSS, a drug side effect, and the laboratory incidents involve handling eggs, sperm and embryos. Restorative reproductive medicine evaluates and treats the cause of infertility in both partners. It works with the body's own cycle, so conception takes place within the body. The report describes three male partners found to have no sperm during a treatment cycle. All three took supplements containing anabolic steroids. Evaluation of both partners before treatment brings male-factor findings of this kind to light.

Abstract not indexed. Read at source

Topics

By this author

Related research

Assisted Reproduction › Safety and Risks › Procedural Safety · Ethics and Policy › Policy and Regulation › Professional Standards
Human Fertilisation and Embryology Authority et al. 2014, Human Fertilisation and Embryology Authority 2014